- CureToday.com
- OncLive.com
- TargetedOnc.com
- CancerNetwork.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Cancer Network Staff | Authors
Articles
Therapeutic Advancements in Multiple Myeloma
January 21, 2021
CancerNetwork spoke with Kenneth C. Anderson, MD, about treatment advances in myeloma - from smoldering, newly diagnosed, and relapsed/refractory multiple myeloma.
Around the Practice: January 2021 Virtual Tumor Board
January 19, 2021
Register for CancerNetwork's live, interactive event featuring leaders in oncology reviewing and discussing patient cases in breast cancer.
Assessing the Small Cell Lung Cancer Treatment Landscape
January 13, 2021
CancerNetwork spoke with Wade T. Iams, MD, about treatment options available and being evaluated in small cell lung cancer.
Optimizing Molecular Testing in Non-Small Cell Lung Cancer
December 18, 2020
With the rise of precision oncology, genomic profiling is growing in its utility to support clinical decision making. Lung cancer experts can use this resource to guide therapy selection in NSCLC. Learning more about advancements in this space can improve patient outcomes and advance the field of precision oncology.
Promising Treatments Emerging for mCRPC and RCC
December 08, 2020
HemePipeline Review
October 14, 2020
Using PARP Inhibitors in Frontline Maintenance Therapy for Ovarian Cancer
October 09, 2020
The use of PARP inhibitors in frontline maintenance therapy has greatly reduced the risk of recurrence in patients with ovarian cancer.
Genetic Testing for Ovarian Cancer
September 15, 2020
Insight on the importance of germline testing and HRD status in ovarian cancer as well as who should be tested.
Overview of Ovarian Cancer
September 14, 2020
Thomas Herzog, MD, reviews the statistics of ovarian cancer in the United States in 2020 including survival rates and types of tumors.